Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Clinical Trial ID NCT00445588

PubWeight™ 5.61^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00445588

Top papers